Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.44 |
| ▸ | LAP3 | P28838 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31752207 | 1.00 | MME (0.55) | MMESLC7A5ALDH1A1MAPTENPEP | |
| SCHEMBL7429977 | 1.00 | MME (0.55) | MMESLC7A5ALDH1A1MAPTENPEP | |
| SCHEMBL7822916 | 1.00 | MME (0.55) | MMESLC7A5ALDH1A1MAPTENPEP | |
| SCHEMBL29870736 | 0.97 | MME (0.53) | MMESLC7A5ALDH1A1MAPTENPEP | |
| SCHEMBL29350942 | 0.95 | MME (0.51) | MMESLC7A5ALDH1A1MAPTENPEP | |
| SCHEMBL30193318 | 0.94 | MME (0.50) | MMESLC7A5ALDH1A1ENPEP | |
| SCHEMBL17803183 | 0.94 | MME (0.50) | MMESLC7A5ALDH1A1ENPEP | |
| SCHEMBL29885518 | 0.92 | MME (0.60) | MMESLC7A5ALDH1A1ENPEPGNPAT | |
| SCHEMBL29414957 | 0.92 | MME (0.51) | MMESLC7A5ALDH1A1MAPTLAP3 | |
| SCHEMBL29630563 | 0.92 | MME (0.51) | MMESLC7A5ALDH1A1MAPTLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085094-A1 | STAPLED PEPTIDE AND USE THEREOF | JIANGSU DEYUAN PHARMACEUTICAL CO LTD (CN) | 2026-03-26 | — | — | US | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| US-20250154226-A1 | LONG-ACTING GLP-1/GLP-2 DUAL AGONIST COMPOUND | Chengdu AODA Biotechnology Co., Ltd (CN) | 2025-05-15 | — | — | US | claimed |
| CN-115466313-B | 1-Imidazole-beta-carboline-3-formyl-LDV, preparation, anticancer metastasis activity and application | 首都医科大学 | 2025-03-28 | — | — | CN | claimed |
| CN-119591674-A | Cyclohexapeptide and preparation method and application thereof | 陕西未来多肽生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-115353547-B | Oleanoyl-Leu-Asp-Val, synthesis, activity and application thereof | 首都医科大学 | 2024-12-27 | — | — | CN | claimed |
| CN-115353546-B | Preparation and application of oligopeptide modified bisindolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2024-10-08 | — | — | CN | claimed |
| EP-4434536-A1 | STAPLED PEPTIDE AND USE THEREOF | Medshine Discovery Inc. (CN) | 2024-09-25 | — | — | EP | claimed |
| WO-2024162422-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | ハウス食品グループ本社株式会社 | 2024-08-08 | — | — | WO | claimed |
| CN-115353547-A | Oleanoyl-Leu-Asp-Val, synthesis, activity and application thereof | 首都医科大学 | 2022-11-18 | — | — | CN | claimed |
| CN-115353546-A | Preparation and application of oligopeptide-modified bis-indolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2022-11-18 | — | — | CN | claimed |
| CN-113501871-B | Method for preparing darunavagon by combining solid phase with liquid phase | 汉肽生物医药集团有限公司 | 2022-10-28 | — | — | CN | claimed |
| CN-115181174-A | Preparation method of Tirzepatide | 深圳市健元医药科技有限公司 | 2022-10-14 | — | — | CN | claimed |
| WO-2022201146-A1 | DERMATOLOGICAL COMPOSITIONS AND USE THEREOF | BONE SCI. BIO LTD. (IL) | 2022-09-29 | — | — | WO | claimed |
| CN-115047120-A | Dansyl chloride derivatization method for analyzing and detecting dipeptide substances in white spirit Daqu | 贵州茅台酒股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-110577582-B | LDV modified heptacyclic aldehyde, synthesis, antithrombotic activity and application thereof | 首都医科大学 | 2022-09-02 | — | — | CN | claimed |
| CN-111995658-B | LDV (laser direct structuring) modified pentacyclic piperazinedione and preparation and application thereof | 首都医科大学 | 2022-08-02 | — | — | CN | claimed |
| CN-114315971-A | Preparation of antibacterial lipopeptide LP21 and application thereof in treatment of bacterial infection | 滨州医学院 | 2022-04-12 | — | — | CN | claimed |
| US-20220105050-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-04-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085094-A1 | STAPLED PEPTIDE AND USE THEREOF | VIP, ARGLU1, NGLY1 | MME 1193/4885SLC7A5 294/4885ALDH1A1 4417/4885 |
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | MME 2240/4885SLC7A5 2919/4885ALDH1A1 3565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.